Skip to main navigation
Skip to search
Skip to main content
University of Birmingham Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Activities
Datasets
Equipment
Prizes
Press/Media
Search by expertise, name or affiliation
NSAIDs and gastrointestinal cancer prevention
Catherine Jolly
,
Kar Cheng
, Michael Langman
Birmingham Medical School
Research output
:
Contribution to journal
›
Article
44
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'NSAIDs and gastrointestinal cancer prevention'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Gastrointestinal Cancer
100%
Cancer Prevention
100%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
100%
Colorectal Cancer
36%
Aspirin
36%
Gastric Cancer
18%
Esophageal Cancer
18%
Primary Prevention
18%
Low Incidence
9%
Adverse Effects
9%
Liver Cancer
9%
Pancreatic Cancer
9%
Risk Reduction
9%
Cancer Incidence
9%
Colorectal Cancer Risk
9%
NSAID Use
9%
Optimal Duration
9%
Relative Risk Reduction
9%
Optimal Dose
9%
Dose-response Relationship
9%
Non-selective NSAIDs
9%
Lack of Information
9%
Gallbladder Cancer
9%
Pharmacology, Toxicology and Pharmaceutical Science
Digestive System Cancer
100%
Non-Steroidal Anti-Inflammatory Drug
100%
Colorectal Carcinoma
41%
Acetylsalicylic Acid
41%
Cohort Study
16%
Abdominal Cancer
16%
Observational Study
16%
Case-Control Study
16%
Liver Cancer
8%
Anti-Inflammatory Drug
8%
Gallbladder Cancer
8%
Cancer Incidence
8%